SERA PROGNOSTICS TO PRESENT AT RBC GLOBAL HEALTHCARE CONFERENCE

About this update from Sera Prognostics, Inc.

[{"type":"text","content":"SALT LAKE CITY , May 14, 2025 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced that the company will present at the RBC Global Healthcare Conference on Wednesday, May 21, 2025, from 9:30 – 9:55 a.m. ET. Zhenya Lindgardt, President and CEO, will participate in a fireside chat and provide a company update and discuss the company's latest achievements.","length":541,"tagName":"p"},{"type":"image","alt":"Sera Prognostics Logo","displaySize":"","headline":null,"caption":"Sera Prognostics Logo","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":90,"url":"https://media.zenfs.com/en/prnewswire.com/b7fe9bcc69a86ef1e2a1d97cd4fcc037"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/Hdy2ncFEPMUCQtRllPjAdw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTE1OTtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/b7fe9bcc69a86ef1e2a1d97cd4fcc037","width":400,"height":90}},"href":"https://mma.prnewswire.com/media/2687539/Sera_Prognostics_Logo.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"A live webcast of the company's presentation as well as a webcast replay will be available online from the Investors page of the company's website at www.sera.com.","length":171,"tagName":"p"},{"type":"text","content":"About Sera Prognostics, Inc.","length":28,"tagName":"p"},{"type":"text","content":"Sera Prognostics is a leading health diagnostics company dedicated to improving the lives of women and babies through precision pregnancy care. Sera's mission is to provide early, pivotal pregnancy information to improve the health of mothers and newborns, resulting in reductions in the costs of healthcare delivery. Sera has a robust pipeline of innovative diagnostic tests focused on the early prediction of preterm birth risk and other complications of pregnancy. Sera's precision medicine PreTRM® Test reports to a physician the individualized risk of spontaneous premature delivery in a pregnancy, enabling earlier proactive interventions in women with higher risk. Sera Prognostics is headquartered in Salt Lake City, Utah.","length":738,"tagName":"p"},{"type":"text","content":"About Preterm Birth","length":19,"tagName"...

More updates from Sera Prognostics, Inc.